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Abstract
Background: Transforming growth factor-beta 1 (TGF-
b1) is a growth factor involved in various biologic pro-
cesses, including peritoneal wound healing and dissem-
ination of malignancies. Laparoscopic surgery is
evolving rapidly, and indications are increasing. The
peritoneal TGF-b1 expression during laparoscopic sur-
gery is unknown.
Methods: For this study, 50 patients scheduled for lap-
aroscopic cholecystectomy were randomized into ﬁve
groups, then surgically treated with various pressures,
light intensities, and dissection devices. Peritoneal
biopsies were taken at the beginning and end of surgery.
Tissue concentrations of total and active TGF-b1 were
measured using enzyme-linked immunosorbent assay
(ELISA) techniques.
Results: There was no signiﬁcant diﬀerence in either total
or active TGF-b1 concentration between peritoneal
biopsies taken at the start of surgery and samples taken at
the end of the procedure. Patients who underwent surgery
with the ultrasonic scalpel had signiﬁcant lower levels of
both active (p<0.005) and total (p<0.01)TGF-b1 at the
end of surgery than patients treated with electrocautery.
Patients who had surgery with a high light intensity had
signiﬁcantly lower levels of total TGF-b1 levels (p <
0.005) with an unchanged active part than patients who
had surgery with low light intensity.
Conclusion: The choice of dissection device and the light
intensity used in laparoscopic surgery aﬀect peritoneal
TGF-b1 concentrations, indicating that peritoneal biol-
ogy can be aﬀected by laparoscopic surgery. Because
TGF-b1 is involved in various biologic processes in the
peritoneal cavity, this observation may have important
clinical consequences.
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Transforming growth factor-beta 1 (TGF-b1) is a nat-
urally occurring growth factor involved in various bio-
logic processes, including peritoneal wound healing and
dissemination of malignancies [1]. Peritoneal wound
healing and subsequent adhesion formation are regu-
lated by a complex mechanism of molecular processes.
Alterations in the local concentrations of cytokines,
growth factors, and proteases all may contribute to the
process of peritoneum healing.
Findings suggest that TGF- b is a major stimulator
of peritoneal adhesion formation [2], mainly by
increasing the peritoneal production of plasminogen
activator inhibitor-1 (PAI-1), which is the main inhibitor
of ﬁbrinolysis and a key factor in adhesiogenesis [3].
Furthermore, TGF-b is a major stimulator of extracel-
lular matrix deposition by inducing the production of
collagen, ﬁbronectin, and integrins [4, 5]. Increased
TGF-b concentrations have been found in the peritoneal
ﬂuid of patients with adhesions and in adhesion tissue
itself [6]. Moreover, postoperative peritoneal adminis-
tration of TGF-b increased adhesion formation in mice,
whereas its inactivation is reported to reduce the inci-
dence of adhesions [7].
By regulating chemotaxis, mitogenisis, and angio-
genesis, TGF-b is involved in dissemination processes
[8]. Secretion of TGF-b and activation of TGF-b sig-
naling pathways have been associated with increased
aggressiveness of several tumor types including pan-
creas, colon, stomach, lung, endometrium, prostate,
breast, brain, and bone tumor [9, 10]. Literature on the
relation of laparoscopic surgery to peritoneal dissemi-
nation and port-site metastasis is controversial.
Endoscopic surgery has developed rapidly in recent
decades. It minimizes the surgical trauma, thereby
reducing recovery time and the incidence of postopera-Correspondence to: Walter J.A. Brokelman
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tive complications. Few studies have suggested that this
strategy also may reduce the incidence of peritoneal
adhesion formation [11]. The eﬀect of laparoscopy on
peritoneal TGF-b1 expression is unknown. Endoscopic
surgery induces new entities in the abdominal cavity
including intense illumination of the peritoneal cavity
and increased intraabdominal pressure. Moreover, the
use of new dissection devices, including the ultrasonic
scalpel, is progressively advocated.
The current study was conducted to evaluate the
hypothesis that peritoneal biology, speciﬁcally perito-
neal TGF-b1 expression, could be aﬀected by laparo-
scopic surgical techniques. The eﬀects of illumination,
intraabdominal pressure, and the choice of dissection




For this study, 50 patients with a diagnosis of symptomatic gallbladder
stone disease and scheduled for elective laparoscopic cholecystectomy
were randomized into ﬁve groups (Table 1). To evaluate the eﬀect of
intraabdominal pressure, three groups of 10 patients each underwent
surgery with intraabdominal pressures of 10 mmHg (group A), 13
mmHg (group B), and 16 mmHg (group C). All three groups had
surgery with the same light intensity and using electrocautery. The
eﬀect of light intensity was studied by comparing a group that had
surgery under a high light intensity (group D) with a group that had
surgery under a low light intensity (group B), using an intraabdominal
pressure of 13 mmHg and electrocautery for both groups. The inﬂu-
ence of the dissection device was assessed by comparing a group that
had surgery using electrocautery (group B) with a group that had
surgery using an ultrasonic scalpel (group E) under equal light inten-
sities and intraabdominal pressures.
Randomization by envelope was done immediately before the
operation. Institutional review board approval was obtained, and
written informed consent was given by the patients before enrollment.
Operative procedure
A uniform technique of videolaparocopic cholecystectomy was ap-
plied, including the use of four trocar ports in the ‘‘American’’ position
and a 0 optic scope. The gallbladder hilum and Calots triangle were
dissected, and metal clips for the cystic duct and artery were used.
Biopsies of the parietal peritoneum were taken with forceps and scis-
sors immediately after carbon dioxide (CO2) insuﬄation and after 45
min of surgery without the use of electrocautery or ultrasonic scalpel.
Within 45 min after the procedure was completed and just before de-
suﬄation, the second biopsy was taken.
Tissue sampling and processing
The peritoneum was carefully dissected, with care taken not to include
the underlying muscle. The tissue specimens were snap frozen in liquid
nitrogen and stored at –70C until further processing. Before homoge-
nization, a sample of thawing peritoneal tissue was cut oﬀ before being
blotted and weighed. Each biopsy was rinsed in phosphate-buﬀered
saline (PBS) with 0.5 M of sodium chloride (pH 7.4), cut into small
pieces, and placed into ice-cold homogenization buﬀer (PBS with 0.01%
Triton X-100 (Sigma, St. Louis, MO, USA) in a ﬁnal tissue concentra-
tion of 40-mg/ml of buﬀer. The tissue was homogenized for 60 s on ice
using a Polytron homogenizer (Ultra Thurrax IKA T-25; Janke &
Kunkel, Staufen,Germany) and centrifuged at 10,000 g for 4min at 4C.
The supernatant then was stored at –70C until further analysis. Tissue
processing and assays were done in batches.
Biochemical assays
Concentrations of active and total TGF-b1 were measured using com-
mercially available enzyme-linked immunosorbent assays (ELISA)
(Promega,Madison,WI,USA). Both the active and total forms ofTGF-
b1weremeasuredbecauseTGF-b is inactivewhenproducedandmust be
activated to become an active cytokine. The active and total amounts of
TGF-b1 were measured in separate steps. First, the active fraction of
TGF-b1was assayed directly in the ELISAplate. Next, the total amount
of TGF-bb1 was assayed by acidifying the samples with 1 mol/l of hy-
drogenchloride to pH 3, followed by a 15 min incubation at 22C,
resulting in an activation of TGF-b1. To neutralize samples, 1 mol/l of
NaOHwas supplemented before addition to the ELISAplate, according
to the instructions from the manufacturer. The lower detection limit for
the TGF-b1 assay was 32 pg/ml. The intraassay variation was 3.3% to
4.5% (CV%), and the interassay variation was 7.6% to 19.1%.
Statistical analysis
Values are given as mean ± standard deviation. Analysis of diﬀer-
ences between groups was performed using the Kruskal–Wallis test
and the Mann–Whitney U test. All tests were two-tailed.
Results
Clinical results
Therewas nodiﬀerence in sex (men, 22%; women, 78%) or
age 51 ± 16 years between the groups. The overall inci-
dence of previous laparotomies was 30%, without diﬀer-
ences between the groups. Moreover, there was no
diﬀerence in the occurrence of intraperitoneal adhesions
or the incidence of bile leakage between the groups. His-
tologic studies of the removed gallbladders demonstrated
no signiﬁcant diﬀerence in the incidence of chronic
inﬂammation between the groups. The timing of the sec-
ond biopsy was equal in all the groups (38 ± 9.2 min).
Biochemical results
Light intensity
The patients who underwent surgery with a high light
intensity had signiﬁcantly lower total TGF-b1 levels (p<
0.005) at the end of surgery than the patients who had
surgery at a low light intensity, as shown by biopsies. The
active TGF-b-1 concentrations were similar in between
the two groups. There were no diﬀerences between the
groups at the start of the procedure (Fig. 1a and b).
Intraabdominal pressure
There was no diﬀerence in the measured total and active
TGF-b1 levels in specimens from patients who had
Table 1. Randomization of the patients scheduled for laparoscopic
cholecystectomy into ﬁve groups
Group Pressure (mmHg) Light intensity (%) Dissection device
A 10 50 Electrocautery
B 13 50 Electrocautery
C 16 50 Electrocautery
D 13 80 Electrocautery
E 13 50 Ultrasonic scalpel
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surgery with intraabdominal pressures of 10, 13, and 16
mmHg (Fig. 2a and b).
Dissection device
Peritoneal biopsies of the patients in whom the dissec-
tion was performed using an ultrasonic scalpel showed
signiﬁcantly lower levels of both total (p < 0.005) and
active (p< 0.01) TGF-b1 at the end of surgery than the
biopsies of the patients who had surgery with electro-
cautery. There were no diﬀerences at the start of the
procedure between the groups (Fig. 3a and b).
There was no diﬀerence among the groups in either
total or active TGF-b1 concentration, as shown by
comparison between peritoneal biopsies taken at the
beginning of the procedure and samples taken at the end
of surgery. When the surgical variation arms were
eliminated and the overall tissue levels before and after
the intervention were compared, no signiﬁcant diﬀer-
ences were found in peritoneal levels between total and
active TGF-b1. There was no diﬀerence in peritoneal
TGF-b1 expression between patients with intraabdom-
inal adhesions and those without adhesions.
Discussion
The current study demonstrated that peritoneal biology
can be aﬀected by laparoscopic surgery, and that vari-
ous surgical techniques may have diﬀerent eﬀects. A
high light intensity and the use of an ultrasonic scalpel
reduced the peritoneal expression of total TGF-b1,
whereas the ultrasonic scalpel also decreased the active
part of TGF-b1. Within clinically applicable variances,
the intraabdominal pressure used had no inﬂuence on
the peritoneal TGF-b1 expression during short-term
laparoscopy.
The use of an ultrasonic scalpel in laparoscopic
surgery is progressively advocated for several reasons
[12–15]. Coagulation of vascular structures is easy and
safe with the ultrasonic scalpel, and there is no eﬀect on
pacemaker function, which is a major drawback of
electrocautery. Most importantly, ultrasonic scalpel is
described as reducing the incidence of gallbladder injury
and iatrogenic bowel perforation, and the operating
time is signiﬁcant shorter [14]. We have demonstrated a
decreased peritoneal expression of both active and total
TGF-b1 when the patient undergoes surgery with the
ultrasonic scalpel. Because TGF-b is a main stimulator
of adhesion formation, the use of an ultrasonic scalpel
may aﬀect the peritoneal healing process by decreasing
expression of type-1 plasminogen activator inhibitor
(PAI-1). In a previous study, however, we did not ﬁnd
any eﬀect of the ultrasonic scalpel on tissue plasminogen
activator (t-PA), urokinase-type plasminogen activator
(u-PA), or PAI-1 levels expressed in the peritoneum of
patients undergoing a laparoscopic cholecystecomy [16].
Schemmel et al. [17] found no diﬀerences in peritoneal
adhesion formation whether traditional incision, elec-
trosurgery, or the ultrasonic scalpel was used in a rabbit
uterine horn model. Similar observations were described
by Tulandi et al. [18] in a rat uterine horn model. At this
writing, clinical data are lacking.
Fig. 1. Total (a) and active (b) transforming growth factor beta 1
(TGF-b1) concentrations in peritoneal samples from the groups with
low (group B) and high (group D) light intensity. Values are median
(horizontal line), interquartile range (boxes), and 10th and 90th per-
centiles (error bars). *p < 0.005.
Fig. 2. Total (a) and active (b) transforming growth factor beta 1
(TGF-b1) concentrations in peritoneal samples from the groups with
intraabdominal pressures of 10 mmHg (group A), 13 mmHg (group B),
and 16 mmHg (group C). Values are median (horizontal line), inter-
quartile range (boxes), and 10th and 90th percentiles (error bars).
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The decreased TGF-b1 expression with the use of the
ultrasonic scalpel may have other important clinical
consequences. For one, TGF-b is involved in various
biologic processes including chemotaxis, mitogenesis,
and angiogenesis, all important in oncologic processes
[19–21]. An increasing proportion of laparoscopic pro-
cedures is performed for oncologic pathology such as
laparoscopic colectomy, nefrectomy, and hysterectomy.
Experimental studies have demonstrated that laparos-
copy is associated with less intraperitoneal tumor
growth than laparotomy, whereas insuﬄation of CO2
may promote peritoneal tumor growth as compared
with gasless laparoscopy [22, 23]. Lecuru et al. [24],
however, did not ﬁnd any deleterious eﬀect of CO2
insuﬄation on ovarian tumor growth as compared with
gasless laparoscopy or midline laparotomy in a rat
model. Only a few clinical data exist to allow assessment
of whether these experimental concerns may be trans-
lated into clinical problems. Velanovich [25] found no
eﬀect of laparoscopy on the occurrence of trocar-site
disease or peritoneal progression of pancreatic cancer.
The observation that the ultrasonic scalpel decreases
TGF-b levels may suggest that this could be the dis-
section device of choice for this type of operation. Our
results warrant further studies focused on this topic.
The eﬀects of light on peritoneal biology are merely
unknown. High temperatures have been described at the
end of a ﬁberoptic bundle of light cables and endoscopes
with both halogen and xenon light sources [26]. This
heat generation is largely attributable to the radiated
power in the visible light spectrum. Increased local
temperature may aﬀect mesothelial cell function,
including the production and release of TGF-b1.
Surprisingly, in the current study, the use of high
light intensity also decreased the levels of total TGF-b1
without aﬀecting its active part. It might have been ex-
pected that high light intensity would lead to increased
damage of the peritoneum and thus to an increase in
TFG-b1. The opposite, however, was true. Laparoscopy
is accompanied by insuﬄation of the peritoneal cavity
with CO2, leading to cooling of the peritoneum and
peritoneal injury. The high light intensity may have
decreased the temperature shift in the peritoneal cavity
due to a higher energy transmission. Additionally, spe-
ciﬁc frequencies of the light may change the biologic
behavior of mesothelial cells. The relation of light and
its speciﬁc frequencies to mesothelial cell biology should
be subjected to further experimental studies.
In the current study, we could not demonstrate an
eﬀect of the used intraabdominal pressure on the peri-
toneal TGF-b1 expression during short-term laparos-
copy. The variations in intraabdominal pressure,
however, may have been too small for any diﬀerences to
be detected because we were limited to clinically appli-
cable variances in intraabdominal pressure.
Molinas et al. [27] demonstrated the eﬀect of pres-
sure on peritoneal wound healing processes. In an
experimental study, they showed that the incidence of
adhesions increases with the pressure of insuﬄation.
Further experimental studies are indicated to elucidate
this subject.
Overall measurements have shown no signiﬁcant
diﬀerence in TGF-b expression between specimens ta-
ken at the start of surgery and biopsies taken at the end
of surgery. The latter, however, may have been too short
for any diﬀerences to be detected, at least at the protein
level. The majority of all endoscopic procedures remain
short-term procedures (<1 hour), including diagnostic
laparoscopy, appendectomy and cholecystectomy, indi-
cating the clinical relevance of the current study. Addi-
tional studies on prolonged endoscopic procedures are
required for further elucidation of the eﬀect that endo-
scopic surgery has on peritoneal TGF-b1 expression.
The timing of the ﬁrst biopsy is another point of
interest. In the current study, the ﬁrst biopsy was taken as
soon as possible after initiation of the pneumoperitone-
um. At that time point, however, the peritoneal layer may
already have been damaged by insuﬄation, which results
in increased abdominal pressure, intense illumination,
and cooling of the peritoneal cavity. This hypothesis is
supported by the observation of Bergstrom et al. [28], who
described higher peritoneal PAI-1 levels immediately
after initiation of a laparoscopic cholecystectomy than
during conventional cholecystectomy. Additional exper-
imental studies are needed to clarify this subject.
In conclusion, the current study suggests that peri-
toneal biology can be modulated by laparoscopic sur-
gery, and that various surgical techniques may have
diﬀerent eﬀects. The use of an ultrasonic scalpel and the
use of higher light intensity decrease peritoneal TGF-b1
levels. The involvement of TGF-b1 in oncologic and
peritoneal repair processes highlights the need for fur-
ther clinical trials.
Fig. 3. Total (a) and active (b) transforming growth factor beta 1 (TGF-
b1) concentrations in peritoneal samples from the groups that had sur-
gery with either electrocautery (group B) or ultrasonic scalpel (group E).
Values aremedian (horizontal line), interquartile range (boxes), and10th
and 90th percentiles (error bars). *p< 0.005, ± p < 0.01.
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